Author in the Room® Teleconference
Joseph Yeboah, MD, MS; Robyn L. McClelland, PhD; Tamar S. Polonsky, MD, MSCI; Gregory L. Burke, MD, MS; Christopher T. Sibley, MD; Daniel O’Leary, MD; Jeffery J. Carr, MD, MSc; David C. Goff, MD, PhD; Philip Greenland, MD; David M. Herrington, MD, MHS
Summary Points:
Interview with Philip Greenland, MD, author of Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals. Summary Points:
- In comparison with other competing biomarkers and risk factors, coronary artery calcium (CAC) is currently the most potent risk marker of subclinical coronary heart disease (CHD).
- CAC was shown in several observational studies to improve the prediction of risk beyond traditional risk factors.
- In this JAMA paper, CAC outperformed various competing risk assessment markers among asymptomatic people at intermediate risk for CHD. Whether CAC should be used in routine clinical practice, however, is still a matter of personal opinion or further research.
All Author in the Room Teleconferences >
JAMA Editor's Audio Summary
September 18, 2012
JAMA 2012-09-18, Vol. 308, No. 11,
Editor's Audio Summary